文献速递青光眼

超越眼内压:优化青光眼患者报告结局

Beyond intraocular pressure: Optimizing patient-reported outcomes in glaucoma.
PubMed 文献 · Prog Retin Eye Res · 2019-10-31

青光眼影响全球40岁以上成人3-4%,眼内压是主要危险因素,但患者报告结局如日常功能、情绪健康等仍是患者最关注的问题。本文非系统性地评述现有青光眼特异性患者中心结局测量(PCOMs)和患者报告结局测量(PROMs)的心理测量学特性、局限与进展,并提出条目库与计算机自适应测试可解决纸质PROMs的多重局限。

要点

  • 青光眼影响全球40岁以上成人3-4%,随人口老龄化将增加。
  • PCOMs显示青光眼患者存在移动、导航、协调挑战及阅读和面孔识别缺陷。
  • PROMs显示青光眼对自报视觉功能、移动、独立性、情绪健康等有负面显著影响。

核心结论

  • 当前青光眼治疗范式的患者中心有效性不明确,因缺乏设计良好的随机对照试验、治疗后随访期短、PROMs选择或可及性不当及现有PROMs对变化不敏感。
  • 作者提出条目库和计算机自适应测试方法可解决纸质PROMs的多重局限、定制其施用并有望改善青光眼患者的医疗结局。

研究设计与样本

  • 非系统性评述,评述现有青光眼特异性PCOMs和PROMs的心理测量学特性、局限与进展。

主要发现

  • 使用PCOMs的研究显示青光眼患者存在移动、导航和协调挑战,阅读和面孔识别缺陷,且适应多种现实情境比健康对照慢。
  • 使用PROMs的研究一致显示青光眼对自报视觉功能、移动、独立性、情绪健康、自我形象和医疗信心有显著负面显著影响,尤其在接受繁重治疗方案的晚期疾病患者中。

局限性

  • 缺乏设计良好的随机对照试验。
  • 治疗后随访期短。
  • PROMs选择或可及性不当。
  • 现有PROMs对变化不敏感,尤其对新诊断早期青光眼患者。
  • 本文为非系统性评述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glaucoma, an irreversible blinding condition affecting 3-4% adults aged above 40 years worldwide, is set to increase with a rapidly aging global population. Raised intraocular pressure (IOP) is a major risk factor for glaucoma where the treatment paradigm is focused on managing IOP using medications, laser, or surgery regimens. However, notwithstanding IOP and other clinical parameters, patient-reported outcomes, including daily functioning, emotional well-being, symptoms, mobility, and social life, remain the foremost concerns for people being treated for glaucoma. These outcomes are measured using objective patient-centered outcome measures (PCOMs) and subjective patient-reported outcome measures (PROMs). Studies using PCOMs have shown that people with glaucoma have several mobility, navigational and coordination challenges; reading and face recognition deficits; and are slower in adapting to multiple real-world situations when compared to healthy controls. Similarly, studies have consistently demonstrated, using PROMs, that glaucoma substantially and negatively impacts on peoples' self-reported visual functioning, mobility, independence, emotional well-being, self-image, and confidence in healthcare, compared to healthy individuals, particularly in those with late-stage disease undergoing a heavy treatment regimen. The patient-centred effectiveness of current glaucoma treatment paradigms is equivocal due to a lack of well-designed randomized controlled trials; short post-treatment follow-up periods; an inappropriate selection or availability of PROMs; and/or an insensitivity of currently available PROMs to monitor changes especially in patients with newly diagnosed early-stage glaucoma. We provide a comprehensive, albeit non-systematic, critique of the psychometric properties, limitations, and recent advances of currently available glaucoma-specific PCOMs and PROMs. Finally, we propose that item banking and computerized adaptive testing methods can address the multiple limitations of paper-pencil PROMs; customize their administration; and have the potential to improve healthcare outcomes for people with glaucoma.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Fenwick EK, Man RE, Aung T, et al. Beyond intraocular pressure: Optimizing patient-reported outcomes in glaucoma. Prog Retin Eye Res. 2019. PMID: 31676347. doi:10.1016/j.preteyeres.2019.100801

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。